Sentence examples for score in prostate from inspiring English sources
The downregulation of EphA5 was also associated with increased Gleason score in prostate cancer.
The second optimal feature is the absolute difference in the value of two drugs' enrichment score in prostate cancer pathway ("abs(hsa05215_1-hsa05215_2)," refer to Supplementary Material III).
Similarly, a loss of stromal Cav-1 is associated with advanced disease and metastasis, as well as a high Gleason score, in prostate cancer patients [ 38].
Similarly, the expression of Stat5 is reportedly higher with Gleason score in prostate cancers (Li et al, 2004; Tan et al, 2008; Thomas et al, 2011).
Expression of VEGF-C and VEGFR3 has been shown to correlate with clinical markers such as concentration of the circulating prostate-specific antigen (PSA) and the Gleason score in prostate cancer [ 13, 15].
Whether increased serum MIF has predictive value that is independent of known predictive markers such as rising PSA values or Gleason score in prostate cancer awaits a larger trial that compares these variables prospectively with PSA levels and patient outcomes.
Additional data has shown significant correlation between elevated ZEB1 expression, induced by androgens, and high Gleason scores in prostate cancer [ 50].
As in all cases analysed immunoreactive scores in benign secretory epithelial cells were ⩾1, the extent of Tiam1 overexpression was calculated as ratio of Tiam1 immunoreactive scores in prostate carcinoma or HG-PIN, respectively, relative to Tiam1 immunoreactive scores in the corresponding benign secretory epithelium in the same section.
In a separate study, we measured ABCD3 expression in African American prostate patients and observed a sustained elevation of ABCD3 in low Gleason score through high Gleason score in AA prostate tumors.
Our findings demonstrate that increased ABCD3 expression correlates with Gleason Score in CA prostate tumors.
As the accuracy of MUC-1 alone or together with the Gleason Score in predicting prostate cancer progression was low, we conclude that its use as a single biomarker in clinical decision making is limited.
